1. Home
  2. CDNA vs VTEX Comparison

CDNA vs VTEX Comparison

Compare CDNA & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • VTEX
  • Stock Information
  • Founded
  • CDNA 1998
  • VTEX 1999
  • Country
  • CDNA United States
  • VTEX United Kingdom
  • Employees
  • CDNA N/A
  • VTEX N/A
  • Industry
  • CDNA Medical Specialities
  • VTEX Computer Software: Prepackaged Software
  • Sector
  • CDNA Health Care
  • VTEX Technology
  • Exchange
  • CDNA Nasdaq
  • VTEX Nasdaq
  • Market Cap
  • CDNA 1.1B
  • VTEX 1.2B
  • IPO Year
  • CDNA 2014
  • VTEX 2021
  • Fundamental
  • Price
  • CDNA $22.94
  • VTEX $6.58
  • Analyst Decision
  • CDNA Buy
  • VTEX Buy
  • Analyst Count
  • CDNA 8
  • VTEX 4
  • Target Price
  • CDNA $26.43
  • VTEX $9.75
  • AVG Volume (30 Days)
  • CDNA 823.5K
  • VTEX 648.2K
  • Earning Date
  • CDNA 02-26-2025
  • VTEX 02-25-2025
  • Dividend Yield
  • CDNA N/A
  • VTEX N/A
  • EPS Growth
  • CDNA N/A
  • VTEX N/A
  • EPS
  • CDNA N/A
  • VTEX 0.05
  • Revenue
  • CDNA $312,775,000.00
  • VTEX $225,906,000.00
  • Revenue This Year
  • CDNA $20.27
  • VTEX $17.10
  • Revenue Next Year
  • CDNA $11.76
  • VTEX $17.73
  • P/E Ratio
  • CDNA N/A
  • VTEX $138.62
  • Revenue Growth
  • CDNA 5.26
  • VTEX 21.27
  • 52 Week Low
  • CDNA $7.42
  • VTEX $5.60
  • 52 Week High
  • CDNA $34.84
  • VTEX $9.59
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 53.43
  • VTEX 59.51
  • Support Level
  • CDNA $21.96
  • VTEX $6.46
  • Resistance Level
  • CDNA $23.80
  • VTEX $6.93
  • Average True Range (ATR)
  • CDNA 1.53
  • VTEX 0.23
  • MACD
  • CDNA 0.09
  • VTEX 0.06
  • Stochastic Oscillator
  • CDNA 45.88
  • VTEX 64.29

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

Share on Social Networks: